Aardvark Therapeutics, Inc. Common Stock (AARD) is a publicly traded Healthcare sector company. As of September 12, 2026, AARD trades at $4.99 with a market cap of $109.64M and a P/E ratio of -1.57. AARD moved +1.00% today. Year to date, AARD is -61.11%; over the trailing twelve months it is -34.15%. Its 52-week range spans $3.35 to $19.58. Analyst consensus is neutral with an average price target of $5.25. Rallies surfaces AARD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover AARD: 0 strong buy, 1 buy, 4 hold, 2 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $5.25.
| Metric | Value |
|---|---|
| Price | $4.99 |
| Market Cap | $109.64M |
| P/E Ratio | -1.57 |
| EPS | $-3.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.58 |
| 52-Week Low | $3.35 |
| Volume | 266.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.35M |
| Net Income | $-69.89M |
| Gross Margin | 0.00% |
7 analysts cover AARD: 0 strong buy, 1 buy, 4 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.25.